Recent Finacing
Recent Raise
Ceregene is a biotechnology company developing AAV-based gene therapies that deliver neurotrophic factor genes to neurons to treat Parkinson’s, Alzheimer’s, and retinal neurodegenerative disorders, with clinical programs underway.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors